Trials / Conditions / ORR,OS,PFS
ORR,OS,PFS
4 registered clinical trials studyying ORR,OS,PFS — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Exploration of Sintilimab + Bevacizumab + AG Chemotherapy as First-Line Treatment for Unresectable Advanced/Me NCT07328802 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 2 |
| Recruiting | Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally A NCT06949033 | Zuoyi Jiao | Phase 3 |
| Recruiting | Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined Wit NCT06925243 | Zuoyi Jiao | Phase 3 |
| Active Not Recruiting | Clinical Study of CD38\CS1 Chimeric Antigen Receptor T Cells in the Treatment of Refractory/Recurrent Multiple NCT06574958 | The Second Hospital of Shandong University | EARLY_Phase 1 |